General AML

Dr. Jonathan Canaani | EBMT 2018 | Are transplant outcomes different in AML patients?


Dr. Jonathan Canaani discussed transplantation outcomes for acute myeloid leukemia (AML) patients at the  44th European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting, 18–21 Mar 2018. Over the last two decades, outcomes of allo-SCT for AML patients have improved as a result of decreased NRM and improved LFS rates. The incidence of relapse has not changed.

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF